
trobicin
Pharmaranks rates Trobicin 3.0/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Trobicin (Spectinomycin Hydrochloride) is a medication used to treat Escherichia Coli Infections, Gonorrhea.
Spectinomycin Hydrochloride · by Pfizer
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Spectinomycin Hydrochloride
- Form
- Injectable
- Strength
- Spectinomycin Hydrochloride EQ 2GM BASE/VIAL · Spectinomycin Hydrochloride EQ 4GM BASE/VIAL
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- escherichia coli infections, gonorrhea
- Manufacturer
- Pfizer
- FDA application
- NDA050347
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
Dosage forms
Injectable
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Trobicin treat?
- Trobicin (Spectinomycin Hydrochloride) may be used to treat escherichia coli infections, gonorrhea, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Trobicin rated?
- pharmaranks gives Trobicin a composite score of 3.0 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Trobicin?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Trobicin. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Trobicin?
- Trobicin is marketed by Pfizer. You can see Pfizer's full profile, rating, and other products on pharmaranks.
- Is Trobicin a brand-name or generic drug?
- Trobicin is a brand-name product with the active ingredient Spectinomycin Hydrochloride.
- Is Trobicin available over the counter?
- No. Trobicin is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Trobicin come in?
- Trobicin is currently marketed as injectable, per the FDA's National Drug Code Directory.
- Is Trobicin FDA-registered?
- Trobicin is on record with the U.S. FDA under application number NDA050347. You can verify this on its official FDA label.
- Has Trobicin been recalled by the FDA?
- Trobicin has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Trobicin safe?
- There's no single safe-or-not verdict. pharmaranks gives Trobicin a recall-safety score of 60/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about SPECTINOMYCIN HYDROCHLORIDE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 3 reports naming SPECTINOMYCIN HYDROCHLORIDE — the active ingredient in Trobicin, and the FDA flagged 100% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- hypersensitivity1 reports
- loss of consciousness1 reports
- malaria1 reports
- muscle spasms1 reports
- pruritus1 reports
- rash1 reports
Read these as a signal, not a rate. A report does not mean SPECTINOMYCIN HYDROCHLORIDE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 26, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
cefixime
Cefixime
cefotan
Cefotetan Disodium
gentamicin sulfate
Gentamicin Sulfate
levofloxacin
Levofloxacin
teflaro
Ceftaroline Fosamil
zymaxid
Gatifloxacin
Compare Trobicin head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
trobicin
60/100